EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Eje microbioma-inmuno-cutáneo y neuro-metabólico en enfermedades inflamatorias crónicas complejas: cohorte transcontinental y algoritmo de predicción terapéutica

Johanna Nathaly Hidalgo Guevara, Juan Andrés Armendáriz Carrasco, Jenifer Pamela Cando Muso, Adriana Vanessa Alcivar Ponce, Karen Joseline Achig Coronel

Salud Medicina e Innovación Journal · 2026

DOI: 10.70577/4sn10c26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Salud Medicina e Innovación Journal, 2026. Verfasst von Johanna Nathaly Hidalgo Guevara und 4 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Complex chronic inflammatory diseases (CCIDs), including psoriasis, inflammatory bowel disease (IBD), atopic dermatitis, and neuropsychiatric disorders, exhibit high comorbidity and share pathophysiological mechanisms mediated by the gut-brain-skin axis (Hawkins et al., 2025; Pearson et al., 2025). Gut microbial dysbiosis, characterized by depletion of short-chain fatty acid (SCFA)-producing taxa and enrichment of pro-inflammatory taxa, emerges as a unifying factor in these conditions (Hawkins et al., 2025).

Objective

To synthesize the available evidence on the microbiome-immune-cutaneous and neuro-metabolic axis in CCIDs, and to evaluate the potential of therapeutic prediction algorithms based on multimodal phenotyping to guide personalized interventions. Methodology: Systematic review following PRISMA 2020 guidelines (Page et al., 2021). A systematic search was conducted in PubMed, LILACS, SciELO and Cochrane for studies published between 2020 and 2026 on the gut-brain-skin axis, multimodal phenotyping and predictive algorithms in CCIDs. Observational studies, technological developments and clinical trials were included. Quality was assessed using the adapted Newcastle-Ottawa scale (Wells et al., 2000).

Results

Eight relevant studies were identified. Evidence confirms that gut dysbiosis, characterized by reduction of Faecalibacterium, Roseburia and Eubacterium, and increase of pro-inflammatory taxa, is consistently associated with CCIDs and their neuropsychiatric comorbidities (Hawkins et al., 2025; Vestergaard et al., 2026). Multi-omics studies have demonstrated significant genetic correlations between IBD and psoriasis (ρ = 0.23-0.25) (Vestergaard et al., 2026). Microbiome-directed interventions, including probiotics, prebiotics and dietary modifications, have shown promising effects in reducing systemic inflammation and improving cutaneous and neuropsychiatric symptoms (Biazzo et al., 2026; Hawkins et al., 2025).

Conclusion

The microbiome-immune-cutaneous and neuro-metabolic axis represents an integrative paradigm for understanding the pathogenesis of CCIDs and their comorbidities. Therapeutic prediction algorithms based on multimodal phenotyping offer a promising pathway for precision medicine, enabling personalized selection of microbiome-directed interventions in the context of transcontinental cohorts.

Zitieren

APA

Guevara, J. N. H., Carrasco, J. A. A., Muso, J. P. C., Ponce, A. V. A., & Coronel, K. J. A. (2026). Eje microbioma-inmuno-cutáneo y neuro-metabólico en enfermedades inflamatorias crónicas complejas: cohorte transcontinental y algoritmo de predicción terapéutica. Salud Medicina e Innovación Journal. https://doi.org/10.70577/4sn10c26

Vancouver

Guevara JNH, Carrasco JAA, Muso JPC, Ponce AVA, Coronel KJA. Eje microbioma-inmuno-cutáneo y neuro-metabólico en enfermedades inflamatorias crónicas complejas: cohorte transcontinental y algoritmo de predicción terapéutica. Salud Medicina e Innovación Journal. 2026. doi:10.70577/4sn10c26

BibTeX
@article{Guevara2026,
  author = {Guevara, Johanna Nathaly Hidalgo and Carrasco, Juan Andrés Armendáriz and Muso, Jenifer Pamela Cando and Ponce, Adriana Vanessa Alcivar and Coronel, Karen Joseline Achig},
  title = {Eje microbioma-inmuno-cutáneo y neuro-metabólico en enfermedades inflamatorias crónicas complejas: cohorte transcontinental y algoritmo de predicción terapéutica},
  journal = {Salud Medicina e Innovación Journal},
  year = {2026},
  doi = {10.70577/4sn10c26}
}
Kostenlos starten →